14 results
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
to several prescription medications and enable innovative tools to help support the switch process.
About STENDRA® (avanafil)
Stendra® (avanafil … , acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
30 Nov 22
Petros Pharmaceuticals Announces Reverse Stock Split
4:05pm
innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Nov 22
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
8:30am
, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Aug 22
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
9:16am
is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
28 Jul 22
Other Events
11:26am
by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including, but not limited to erectile
8-K
EX-99.1
s8j64kk1pd7u5wn6vad3
26 Apr 22
Other Events
4:30pm
8-K
EX-99.1
z23vljx ac03syc
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-99.1
shcr8ahnzqa fxq
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
8-K
EX-99.1
l42sf j421
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
8-K
EX-99.1
39p9jftwd5rt
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
qs6w3 8uhi6679r7ut
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
8-K
EX-99.1
sgi0mkq7d87mqgbuoyx
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
- Prev
- 1
- Next